Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients
- Conditions
- Oncology
- Interventions
- Other: Results of the brief geriatric assessmentOther: No results of brief geriatric assessments
- Registration Number
- NCT03951090
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Brief Summary
This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.
- Detailed Description
This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (\> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.
This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 148
- Age 70 years or older.
- English speaking.
- Admitted to UNC Hospitals non-electively within 72 hours.
- Biopsy proven solid tumor or myeloma or lymphoma.
- Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
- Signed written IRB-approved informed consent.
- Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
- Patients who are <48 hours post-surgery.
- Patients who are admitted to an intensive care setting.
- Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
- Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description GARRT Arm Results of the brief geriatric assessment Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment Control Arm No results of brief geriatric assessments Providers of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment
- Primary Outcome Measures
Name Time Method Referral rate for GA-identified deficits in intervention and control groups 2 years Number of participants with at least one referral for a GA-idenfied deficit
- Secondary Outcome Measures
Name Time Method Referral to Physical and Occupational therapy 2 years Number of times physical and occupation therapy referral was given in Intervention and Control group
Referral to Geriatic Consultation 2 years Number of times a Geriatric Consultation referral was given in Intervention and Control group
Referral to Clinical Pharmacist 2 years Number of times Clinical Pharmacist referral was given in Intervention and Control group
Referral to Nutritionist 2 years Number of times Nutritionist referral was given in Intervention and Control group
Referral to psyhcosocial support team 2 years Number of times psychosocial support referral was given in Intervention and Control group
Physician Reported New information 2 years Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"
Physician Reported Satisfaction 2 years Number of times physician indicate "yes" report was helpful when asked "Is this report useful"
Trial Locations
- Locations (1)
UNC Lineberger Comprehensive Cancer Center
🇺🇸Chapel Hill, North Carolina, United States